Company Profile

Svas Biosana S.p.A. is specialized in the manufacture and distribution of medical devices for public and private health institutions. The group's business is organized around 2 poles:
- production and sale of medical devices (Svas Biosana, Medical and FARMEX): incontinence aids, dressings, hygiene and personal care products, procedural packs for operating rooms, surgical instruments, infusion and suction systems, etc.;
- distribution of medical devices (Mark Medical): business operations conducted in Slovenia, Croatia, Bosnia-Herzegovina and Serbia.
At the end of 2025, the group had 3 manufacturing sites in Italy.
Net sales are distributed geographically as follows: Italy (48.3%), European Union (34.4%) and other (17.3%).


Source: Cofisem - Last Update: 2026-06-03

Key Executives
Chairman and Chief Executive Officer Filippo Maraniello
Head of Investor Relations Andrea Efficace


Source: Cofisem - Last Update: 2026-06-03

Key Figures
Millenium 2025 2024 2023 2022 2021
Net sales 139,113 120,315 118,284 97,227 81,085
Consumed purchases 83,457 71,657 72,112 56,398 44,740
Labour costs 16,578 14,464 13,763 12,676 11,022
Operating profit 12,237 9,803 8,567 6,257 5,771
Income tax 2,369 2,133 1,672 1,085 857
Net income 6,768 5,877 5,126 3,571 3,161
Net income (Group share) 6,770 5,875 5,123 3,569 3,159
Fiscal year end 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards Local GAAP Local GAAP Local GAAP Local GAAP Local GAAP

Source: Cofisem - Last Update: 2026-06-03

Shareholder information
21 Monte Somma S.r.l. 43.86 %
Free float 25.35 %
Cofi Italia S.r.l. 8.19 %
Danila Antonia Perillo 6.35 %
Belforte S.r.l. 5.46 %
Anima SGR S.p.A. 5 %
Treasury shares 4.86 %
Agrinvest S.r.l. 0.93 %


Source: Cofisem - Last Update: 2026-06-03

Please contact MyQuestion.Italy@euronext.com for Company Profile support.

Quotazioni, Book, Dividendi, Documenti Societari, Corporate Governance, Internal Dealing di Svas Biosana


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.